Diabetes mellitus (DM) is a multifactorial metabolic disorder characterized by hyperglycemia that induces damage across multiple organs, including the lungs. Recent evidence suggests that Nod-like receptor protein-3 (NLRP3)-mediated pyroptosis contributes significantly to diabetic complications.
(2025). Vildagliptin and Linagliptin Inhibit NLRP3 Pyroptosis in Diabetic Lungs. Egyptian Society of Diabetes and Lipidology Journal, 5(2), -. doi: 10.21608/esdlj.2025.456301
MLA
. "Vildagliptin and Linagliptin Inhibit NLRP3 Pyroptosis in Diabetic Lungs", Egyptian Society of Diabetes and Lipidology Journal, 5, 2, 2025, -. doi: 10.21608/esdlj.2025.456301
HARVARD
(2025). 'Vildagliptin and Linagliptin Inhibit NLRP3 Pyroptosis in Diabetic Lungs', Egyptian Society of Diabetes and Lipidology Journal, 5(2), pp. -. doi: 10.21608/esdlj.2025.456301
VANCOUVER
Vildagliptin and Linagliptin Inhibit NLRP3 Pyroptosis in Diabetic Lungs. Egyptian Society of Diabetes and Lipidology Journal, 2025; 5(2): -. doi: 10.21608/esdlj.2025.456301
)
